When a peripheral lung abscess fails to respond to systemic intravenous antibiotic therapy within the expected timeframe, a defined next-line intervention is indicated. This protocol addresses the specific anatomy and the escalation criteria that trigger it.
The abscess is located peripherally, with none to very little normal lung parenchyma between the abscess and the parietal pleura. This distinguishes it from central or proximal abscesses and is the key anatomical feature that determines the approach.
Prior therapy: Conservative management with systemic intravenous antibiotics (7–14 days).
Goals not achieved: Clinical symptoms were expected to begin improving within the first 4 days. Clinical and radiological improvement of the abscess was expected by 7–14 days. Failure to reach either benchmark is the trigger for escalation.
DOI: 10.21037/jtd-23-1561
PTTD should be reserved for peripheral abscesses with none to very little existing normal lung parenchyma near the parietal pleura and the abscess.
All abscesses improved according to clinical and radiographic criteria.
View source ↗